Adriamycin CS Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Adverse reactions reported in association with doxorubicin therapy are listed in Table 3 by MedDRA System Organ Class and by frequency. Frequencies are defined as: Very common (≥10%), Common (≥1%, <10%), Uncommon (≥0.1%, <1%), Rare (≥0.01%, <0.1%), Very rare (<0.01%) and Not known (cannot be estimated from available data). (See Table 3.)

Click on icon to see table/diagram/image

Intravesical use: Systemic toxicity is not a common problem, however, adverse reactions have been noted at doses exceeding that recommended (see Dosage & Administration).
Local reactions observed include chemical cystitis, contraction of the bladder, haematuria, painful micturition, frequency and urgency. These disturbances are transient.

View ADR Reporting Link

Adriamycin CS Adverse Reactions

doxorubicin

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma